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The effects of endothelin-1 (ET-1) on endothelial cells from the porcine coronary artery were investigated using cascade bioassay and radioimmunoassay methods. For indomethacin significantly attenuated the relaxation induced by perfusate from the endothelial cells of the porcine coronary artery. In endothelium-intact strips of the porcine coronary artery, ET-1 significantly increased the concentration of 6-ketoprostaglandin F,a but did not modify the cellular concentration of either cAMP or cGMP. It is concluded that ET-1 augments the release of vasorelaxing factors from endothelial cells both in the porcine coronary artery and in the rabbit abdominal aorta and that the major vasorelaxing substance derived from endothelial cells may be different in these two blood vessels. Prostaglandin 12 in the former and nitric oxide in the latter are suggested as possible candidates. The vasorelaxation induced by prostaglandin 12 may not be mediated by cAMP-dependent mechanisms in the porcine coronary artery. (Circulation Research 1991;69:1361-1368) T he vascular endothelium has an important role in the determination of vascular tonus. A number of hormones or autacoids act on endothelial cells and activate the release of vasoactive substances, including endothelium-derived relaxing factor (EDRF),' endothelium-derived hyperpolarizing factor,2 prostaglandin 12 (PGI2),3 and endothelium-derived contracting factor, which then modulate the tonus of vascular smooth muscles. [4] [5] [6] [7] [8] As a result of the findings of Furchgott and Zawadzkil in 1980, the role of endothelium-derived vasorelaxing factors have recently received much attention. It has been found that a 21-amino acid peptide, named endothelin, is produced in cultured porcine aortic endothelial cells and that this peptide has been shown to be a very potent vasoconstrictor.9
Later, it was also found that three types of endothelin-related genes exist and that the endothelin-1 (ET-1) isoform is expressed in mammalian endothelial cells.10 Studies on various vascular beds have shown that ET-1 induces a vasoconstriction at a concentration significantly lower than that of any other known spasmogenic agent, both in' vivo and in vitro. 8, 9 Apart from this potent vasoconstrictive property, ET-1 also has the vasodilatory actions in the presence of the intact endothelium. For example, an intravenous bolus injection of ET-1 caused a transient decrease and a subsequent increase in systemic blood pressure in rats with chemically denervated sympathetic nerves9 and in pithed rats." These results indicate that the depressor effects of ET-1 are not mediated by the activation of sympathetic nerves. Thus, the vasodilatory actions of ET-1 are, most likely, the consequence of an augnented liberation of vasodilatory substances from vascular endothelial cells.12 However, the characteristic features of the endothelium-derived vasorelaxing substances have not been well studied in the porcine coronary artery. To clarify this, we carried out a cascade bioassay using enzymatically dispersed, freshly isolated vascular endothelial cells derived from the porcine coronary artery. Since the properties of endotheliumderived vasorelaxing substance have been well studied in the rabbit aorta,6 endothelial cells from the rabbit abdominal aorta were also used, and the results were compared with those observed with endothelial cells from the porcine coronary artery.
Materials and Methods

Materials
The left anterior descending coronary artery was excised from a fresh porcine heart after slaughter, rinsed free of blood, and cleaned by removal of connective tissue in Krebs' solution under a biocular microscope at room temperature. The main trunk of the left anterior descending coronary artery was used to obtain endothelial cells for the cascade bioassay and for the measurements of prostaglandin E2
(PGE2), 6 -ketoprostaglandin F,,, (6-keto-PGFIcr), cAMP, and cGMP. The distal branches near the apex were used for isometric tension measurements.
Male albino rabbits (1.9-2.5 kg) were anesthetized by injection of pentobarbital sodium (40 mg/kg i.v.) and exsanguinated. The abdominal aorta was excised and cleaned by removal of connective tissue in Krebs' solution.
Drugs
Commercial bovine hemoglobin, containing 75% methemoglobin, was dissolved into pure water and reduced by adding 20 mM sodium thiosulfate to 2 mM hemoglobin. Dialysis with 1,000x vol pure water was carried out at 4°C to remove excess sodium thiosulfate. 13 The identification and final concentration of oxyhemoglobin (Hb) were determined spectrophotometrically.
Drugs used were ET-1 (Peptide Institute, Osaka, a small razor blade, as reported previously.14 The strip was then transferred into a small 1.0-ml chamber, through which test solutions could be changed rapidly by injecting fresh solution into one end and by sucking simultaneously from the other end with a water pump.15 Both ends of the preparation were fixed between pieces of Scotch double-sided tape with thin silk thread, and isometric tension was recorded using a strain-gauge transducer (U-gauge, Shinko Co., Tokyo). The resting tension was adjusted to obtain a maximal contraction in 128 mM K'. In the present experiments, removal of endothelium was not confirmed histologically. Instead, the functional removal of endothelium was tested by application of 0.1 1M A23187 on the tonic contraction induced by 0.3 ,M ACh, as described previously.'416 A23187 (0.1 ,uM) attenuated the tonic contraction induced by 0.3 ,uM ACh in endothelium-intact strips but not in endothelium-denuded ones. These results suggest that adequate functional denudation of the endothelium had occurred. All experiments were performed at room temperature, 23-25°C.
Cascade Bioassay
The main trunk of the porcine left anterior descending coronary artery or the rabbit abdominal aorta was cut along the long axis and gently washed with Krebs' solution to remove blood cells, and then the strip was treated with 200 picounits/ml Dispase in modified Krebs' solution (Ca'4 concentration was decreased to 0.26 mM) at 32°C for 45 minutes. The dispersed endothelial cells were collected by application of a jet stream of Krebs' solution from an injector on the intimal side of the strips. The cell suspension was transferred to a small 2.0-ml chamber with a filter membrane (0.45-,um pore size, Millipore Corp., Bedford, Mass.) and was gently perfused with gassed (95% 02-5% C02) Krebs' solution at a constant flow rate of 2.5 ml/min using a peristaltic pump. The perfusate that passed through the filter membrane was collected every 30 seconds in a syringe and immediately injected (within 5 seconds) into the other chamber, where an endothelium-denuded strip of the porcine coronary artery was precontracted with 1 nM ET-1. ET-1 was added in the collected perfusate to make a final concentration of 1 nM if it did not contain ET-1.
Hb (10 ,M) was directly added to the collected perfusate, which was then mixed briefly before injection. Hb was also added to the recipient strip 3 minutes before injection of the perfusate to allow compensation for its direct action on the recipient vascular smooth muscle.
Indomethacin (10 ,M) was added to the perfusion solution for 1-2 hours. After this period, the perfusion solution was changed to the control Krebs' solution for 10 minutes to prevent the direct action of this drug on the recipient vascular smooth muscle.
Assays for 6-Keto-PGFI,, Anterior descending coronary arteries were dissected from fresh porcine hearts and cleaned by removal of connective tissue. They were allowed to equilibrate in Krebs' solution for 2 hours at 32°C. The strips were transferred into tubes containing 2 ml Krebs' solution and were equilibrated for 1 hour, and then ET-1 (final concentration of 1 nM) was added to the tube for 3 minutes. For the assay, 0.1 ml solution was taken out, and the concentration of 6-keto-PGFla was measured using a radioimmunoassay kit purchased from Amersham International. To normalize the concentrations, the strips were dried and weighed, and the content of 6-keto-PGFia was expressed per milligram dry weight tissue for 3 minutes. Production of 6-keto-PGFia in the rabbit abdominal aorta was also measured in the same manner.
Assays for cAMP and cGMP
Muscle strips of the porcine coronary artery were prepared as described above. In some strips, endothelial cells were gently removed using small razor blades. The functional removal of endothelium was tested by the lack of A23187-induced vasorelaxation on the contraction induced by 0.3 ,M ACh in some typical strips, as described above. ET-1 (0.1 and 1 nM) was applied for 3 minutes after equilibration for 2 hours, and the reaction was halted by soaking the strips with 8% trichloroacetic acid. Strips were pretreated with methylene blue (10 ,uM) and indomethacin (10 ,uM) for 30 minutes and 2 hours, respectively, before and during application of ET-1. The strips were then homogenized in the solution containing trichloroacetic acid using a glass homogenizer. 17 The homogenate was centrifuged, and the pellet was used for protein assay. 18 The supernatant fraction was treated with water-saturated ether three times and assayed for cAMP and cGMP using radioimmunoassay kits from Amersham International.
Concentration of cGMP in the rabbit abdominal aorta was also measured in the same manner.
Statistics
The values measured were expressed as mean+ SEM. Differences between means within each experiment were evaluated by analysis of variance. If significant differences were demonstrated, Student's t test was used to determine which pairs of means were significantly different. Values ofp<0.05 were considered significant.
Results
Effects of ET-] on Mechanical Activities in Endothelium-Intact and -Denuded Smooth Muscle Strips of the Porcine Coronary Artery
To study the roles of the endothelium in the modulation of the mechanical activity of the porcine coronary artery, the maximum amplitudes of contraction induced by 128 mM K', 10 ,M ACh, and 10 nM ET-1 were compared in endothelium-intact and -denuded strips. Since Hb (10 iM) and indomethacin (1 IM) did not modify the maximum amplitude of contraction induced by 128 mM K+ in endothelium- intact strips, the maximum amplitude of contraction induced by 128 mM K+ was used to normalize the contraction of the strips. In the endothelium-intact strips, the maximum amplitude of contraction induced by 10 nM ET-1 was larger than that obtained by 128 mM K+ (1.44 times) and was the same as that induced by 10 ,uM ACh ( Figure 1 ). In endotheliumdenuded strips, 10 nM ET-1 produced the largest contraction of the above three stimulants. Figure 2 shows the dose-response relation curves for ET-1 in endothelium-intact and -denuded strips of the porcine coronary artery. Various concentrations of ET-1 were applied cumulatively to the strip in a stepwise manner. The maximum amplitude of contraction induced by 10 nM ET-1 was expressed as a relative tension of 100%. strips, the minimal concentration of ET-1 needed to produce an effect was 0.3 nM, and the maximal response was obtained at 10 nM. The dose-response relation of ET-1 was shifted to the left in the endothelium-denuded strips; that is, the threshold concentration of ET-1 required to produce a contraction was lower, and the maximal contraction was obtained at 3 nM (EC50 was -0.3 nM).
Characteristics of ET-1-Induced Response of Vascular Endothelium To study the actions of the endothelium on ET-1-induced contraction more directly, we developed a cascade bioassay system using isolated endothelial cells of the porcine coronary artery as a donor and endothelium-denuded smooth muscle strips of the same arteiy as a recipient. In some experiments, endothelial cells of the rabbit abdominal aorta were also used as a donor to compare with the results observed using endothelial cells of the porcine coronary artery. Endothelial cells from either blood vessel were constantly perfused with Krebs' solution in the presence or absence of 1 nM ET-1. The perfusate collected at 30-second intervals was applied to endothelium-denuded strips of the porcine coronary artery, which were precontracted with 1 nM ET-1.
After a constant amplitude of contraction was attained in the presence of 1 nM ET-1, the perfusate from the endothelial cells of porcine coronary artery in the absence of ET-1 was applied to the strip after adjusting the concentration of ET-1 to 1 nM. As shown in Figure 3 , the perfusate reduced the amplitude of the contraction induced by 1 nM ET-1. When the endothelial cells were perfused with 1 nM ET-1, this perfusate significantly increased the extent of the relaxation (the relaxation was 19.8+±2.8% in control and 42.7±5.5% in the presence of 1 nM ET-1, n=13, p<O.Ol).
Hb (10 ,uM) only slightly attenuated the augmented relaxation (33.9 ± 6.5%, n = 8). In contrast, 10 ,uM indomethacin significantly attenuated the perfusate-induced relaxation (17.9±4.0%, n=10,p<0.01). With a combination of 10 pM Hb and 10 ,uM indomethacin, the perfusate-induced vasorelaxation was almost completely blocked (2.5±0.8%, n =7, p<0.01). Figure 4 shows the effects of the perfusate from endothelial cells of the rabbit abdominal aorta on ET-1-induced contraction in the endotheliumdenuded strips of porcine coronary artery. Before the application of ET-1, the perfusate attenuated the contraction induced by 1 nM ET-1 in endotheliumdenuded strips of the porcine coronary artery (19 
Production of PGI2
PGI2 is synthesized in vascular endothelial cells and causes vasodilatation.5 To study the effects of ET-1 or ACh on changes in the concentration of PGI2, the perfusate that passed through the endothelium-intact or -denuded strips of the porcine coronary artery in the presence or absence of 1 nM ET-1 or 10 ,uM ACh was collected for 3 minutes, and the amount of 6-keto-PGFia (a stable metabolite of PGI2) was measured. Under resting conditions, the concentrations of 6-keto-PGFia were 6.21 ± 1.00 ng/mg dry wt/3 min and 0.68±0.26 ng/mg dry wt/3 min in the endothelium-intact and -denuded strips, respectively. ET-1 (1 nM) or ACh (10 ,uM) significantly increased the concentration of 6-keto-PGFia in the endothelium-intact strips (p<0.05) but not in the endothelium-denuded strips of the porcine coronary artery ( Figure SA) . The synthesis of 6-keto-PGF1, was inhibited by 10 ,uM indomethacin in the endothelium-intact strips. However, 1 nM ET-1 did not increase the amount of PGE2 in the perfusate that passed through the endothelium-intact strips of porcine coronary artery.
ET-1 (1 nM) also increased the concentration of Under the resting conditions, the concentrations of 6-keto-PGFla were 0.12±0.03 ng/mg dry wt/3 min and 0.05±0.01 ng/mg dry wt/3 min in endotheliumintact and -denuded strips, respectively (n=4). ET-1 (1 nM) significantly increased the concentrations of 6-keto-PGFia in the perfusate that passed through the endothelium-denuded strips ( Figure SB, n=4, p<O.OS), but the amount of 6-keto-PGF1, produced in the rabbit abdominal aorta was much smaller than that in the porcine coronary artery. Accumulation of cAMP and cGMP It is well known that EDRFs increase cellular cGMP levels in vascular smooth muscle and that this closely correlates with their vasodilating actions. 6 Methylene blue inhibits both responses induced by EDRF.7 To study the relation between cellular cGMP concentration and perfusate-induced vasodilatation, the effects of ET-1 (0.1 and 1 nM) with or without 10 ,M methylene blue on the concentration of cGMP were observed in endothelium-intact and the -denuded strips of the porcine coronary artery. Under resting conditions, the concentrations of cGMP were 2.55+0.22 and 1.4+0.4 pmol/mg protein in the endothelium-intact and -denuded strips (n =8), respectively. Methylene blue (10 gM) significantly reduced the concentration of cGMP in both strips (concentrations were 0.7+0.2 and 0.6+0.2 pmol/mg protein in endothelium-intact and -denuded strips, respectively, n=3,p<0.01). ET-1 (0.1 and 1 nM) did not modify the concentration of cGMP in the endothelium-intact and -denuded strips in the presence or absence of 10 ,M methylene blue. Nitroglycerin (10 ,uM) significantly increased the cGMP content of the endothelium-denuded strips of porcine coronary artery ( Figure 6A , p<O.OS). In endothelium-intact strips of the rabbit abdominal aorta, 1 nM ET-1 slightly, but not significantly, increased the amount of cGMP ( Figure 6B ).
Since PGI2 increases cAMP concentration and this may cause vasodilatation in some arteries,5 the effects of ET-1 (0.1 and 10 nM) on the change in concentration of cAMP were studied in endotheliumintact or the -denuded strips of porcine coronary artery (Figure 7 ). In the absence of ET-1, the cellular concentrations of cAMP were 5.0+0.7 (n=8) and 4.7+±0.8 (n=6) pmol/mg protein in endotheliumintact and -denuded strips, respectively, and were not significantly different. ET-1 (0.1 and 10 nM) did not modify the concentration of cAMP in endotheliumintact or -denuded strips. Indomethacin (10 ,M) did not modify the cAMP content in either of the strips in the presence or absence of 1 nM ET-1. In endothelium-intact strips, the content was 5.0±+0.7 pmol/mg protein in control and 6.5±1. the cAMP content of the endothelium-denuded strips ( Figure 7 ). These results indicate that endothelium attenuates the ET-1-induced contraction without a corresponding change in the concentration of cAMP or cGMP in the porcine coronary artery.
Effects of PGI2 on ET-1-Induced Contraction in Endothelium-Denuded Strips of the Porcine Coronary Artery
The effects of PGI2 on the contraction induced by 1 nM ET-1 were observed in endothelium-denuded strips of the porcine coronary artery. As shown in Figure 8 , PGI2 dose-dependently attenuated the steady-state amplitude of contraction induced by 1 nM ET-1. The minimal concentration of PGI2 needed to attenuate the contraction induced by 1 nM ET was 30 nM (the attenuation was 10.2+2.4%, n=3), and maximal attenuation was obtained at 10 ,uM (75.3+±6.3%, n=4). The vasodilating actions of PGI2 were reproducible when repetitively applied. Isoprenaline (10 nM and 100 nM) dose-dependently attenuated the steady-state amplitude of contraction induced by 1 nM ET-1 in endothelium-denuded strips of the porcine coronary artery (the attenuation was 18.5 ±3.2% at 10 nM and 88.5±5.8% at 100 nM, n=4). Discussion ET-1 is synthesized in porcine and human endothelial cells and is a very potent vascular constrictor in the porcine coronary artery.9 It was recently found that the vasoconstriction induced by ET-1 is significantly reduced in the presence of intact endothelium711 In the present experiments, we confirmed this; with endothelium-denuded strips, the maximum amplitude of contraction induced by 10 nM ET-1 was 1.8 times greater than that observed in endotheliumintact strips. The dose-response relation of ET-1-induced contraction was shifted to the left in the endothelium-denuded strips. These results suggest that, in the porcine artery, ET-1, which is synthesized in endothelial cells, also acts on the endothelial cells9 and releases some vasorelaxing factors, which in turn attenuate the vasoconstriction induced by ET-1 itself.
The study of de Nucci et all' demonstrated that ET-1 releases PGI2 in guinea pig or rat isolated lung and EDRF in the perfused mesentery of the rat. The vasodilative responses are attenuated by indomethacin in guinea pig or rat isolated lung and by Hb in the perfused rat mesentery. Kauser et a119 suggested that ET-1 exerts a direct vasoconstrictor effect on cat cerebral vascular smooth muscle, which is opposed by the release of cyclooxygenase metabolite(s) from the endothelium. These results suggest that ET-1 activates the release of different vasodilative substances in different species or in different types of blood vessels. However, the substances released by have not yet been determined in the endothelial cells of the porcine coronary artery.
To clarify this, we used a new cascade bioassay method with enzymatically dispersed, freshly prepared endothelial cells from the porcine coronary artery as a donor because there were some disadvantages to the bioassy cascade methods used before (i.e., when the endothelium-intact vascular strips were used as a donor, the perfusate may have contained vasoactive substances derived from nerves or smooth muscles in addition to those from the endothelial cells in the strips). Cultured endothelial cells can be used to obtain substances released only from endothelial cells. However, in primary cultures of endothelial cells, some peptides do not produce physiological responses in rabbit aorta. 20 In the present experiments, we found that the perfusate that passed through the freshly isolated endothelial cells continued to attenuate the ET-1-induced contraction for over 2 hours in the absence of any stimulants, suggesting that the spontaneous release of vasorelaxing factors from the endothelial cells was constant. Further, the perfusate from the endothelial cells attenuated the extent of contraction to a greater degree when the endothelial cells were perfused in the presence of 1 nM ET-1 (2.1 times the control). In preliminary experiments, we obtained almost the same results when the endothelium-intact strips of porcine coronary artery were used as a donor. These results indicate that the freshly isolated endothelial cells retain the physiological actions of ET-1 on the synthesis and release of vasorelaxing factors. Similar results were obtained when freshly isolated endothelial cells from the rabbit abdominal aorta were used.
It has been supposed that, in the rabbit aorta, EDRF may be nitric oxide or its related compounds.1 21 EDRF increases the cGMP concentration in vascular smooth muscle, and this causes vascular relaxation.22 Hb inhibits the increase in the concentration of cGMP and the vasodilatation induced by either EDRF or nitric oxide through an inactivation of nitric oxide. 23 We partly confirmed these findings in the present experiment in the rabbit aorta; that is, when endothelial cells from the rabbit abdominal aorta were used, Hb (10 ,uM) completely blocked the perfusate-induced vasorelaxation. In contrast, with endothelial cells from the porcine coronary artery, Hb (10 ,uM) itself only marginally attenuated the perfusate-induced vasodilatation, but indomethacin (10 /lM) greatly diminished it. In the endotheliumintact strips of porcine coronary artery or rabbit abdominal aorta, ET-1 did not significantly increase the amount of cGMP, although this peptide greatly increased the perfusate-induced vasorelaxation. The amount of cGMP in the presence of endothelium is 5.4 and 1.9 times larger than that in the absence of endothelium in the rabbit abdominal aorta and porcine coronary artery, respectively. This may suggest that a larger amount of nitric oxide is liberated from endothelial cells of the rabbit abdominal aorta than from those of the porcine coronary artery and that a slight increase in nitric oxide induced by ET-1 causes a large response. It remains to be clarified. These results suggest that some cyclooxygenase products derived from the endothelial cells may have essential roles in modulating the perfusate-induced vasorelaxation in the porcine coronary artery.
Among the cyclooxygenase products in some vascular beds, PGI2 and PGE2 are well-known potent vasodilators. 24 The amounts of both prostaglandins released from the strips of porcine coronary artery were higher when the endothelium was intact than they were when the artery was endothelium-denuded. ET-1 (1 nM) increased the perfusate-induced vasorelaxation and the amount of 6-keto-PGF1,, but not PGE2, in the endothelium-intact strips. We also confirmed that ET-1 (1 nM) increased the amount of 6-keto-PGFl, in the perfusate when single endothelial cells of the porcine coronary artery were used. PGI2 in concentrations >30 nM attenuated the ET-1-induced contraction of the endothelium-denuded strips of the porcine coronary artery. These results suggest that the main endothelium-derived vasorelaxing substance may be PGI2 in the porcine coronary artery.
In the present experiments, Hb enhanced the inhibitory actions of indomethacin on the perfusateinduced vasorelaxation, although Hb itself had no direct effects on the vasorelaxation induced by the perfusate in the porcine coronary artery. These results suggest that, in the presence of ET-1, the perfusate that passes through the endothelial cells may contain a small amount of the Hb-sensitive component nitric oxide, which is not enough to produce an ET-1-dependent cellular cGMP increase in endothelium-intact strips under these experimental conditions. In agreement with this hypothesis, Christie et a125 recently reported that in response to ACh, rabbit aortic endothelium released EDRF at a significantly greater maximum rate than did pig coronary arterial endothelium. Synergistic interactions between PGI2 and EDRF have been suggested to occur in the inhibition of platelet aggregation and in the relaxation of smooth muscle.26
In some vascular tissues, it has been suggested that PGI2 increases the cellular concentration of cAMP and that this causes vasorelaxation.5,27 However, Schror and R6sen28 reported that PG12 relaxes bovine coronary artery in a dose-dependent manner but decreases the cAMP level in the strips. In the present study, ET-1 or PGI2 did not increase the cAMP content in endothelium-intact and -denuded strips of the porcine coronary artery. In contrast, 10 nM isoprenaline significantly increased cAMP in endothelium-denuded strips under the same assay conditions. These results indicate that in the porcine coronary artery the perfusate that passes through the endothelial cells of porcine coronary artery or PGI2 induces vasodilatation without the mediation of cAMP-dependent mechanisms.
In conclusion, in the porcine coronary artery, it has been determined that ET-1 is capable of releasing factors that attenuate its own vasoconstrictive activities and that PGI2 attenuates the ET-1-induced contraction without altering cellular cAMP levels. In contrast, ET-1 stimulates the liberation of nitric oxide from endothelial cells of the rabbit abdominal aorta.
